BIIB
$144.89
Revenue | $2645.5Mn |
Net Profits | $634.8Mn |
Net Profit Margins | 24% |
PE Ratio | 13.75 |
Biogen Inc.’s revenue jumped 7.33% since last year same period to $2645.5Mn in the Q2 2025. On a quarterly growth basis, Biogen Inc. has generated 8.82% jump in its revenue since last 3-months.
Biogen Inc.’s net profit jumped 8.77% since last year same period to $634.8Mn in the Q2 2025. On a quarterly growth basis, Biogen Inc. has generated 163.95% jump in its net profits since last 3-months.
Biogen Inc.’s net profit margin jumped 1.35% since last year same period to 24% in the Q2 2025. On a quarterly growth basis, Biogen Inc. has generated 142.55% jump in its net profit margins since last 3-months.
Biogen Inc.’s price-to-earnings ratio after this Q2 2025 earnings stands at 13.75.
EPS Estimate Current Quarter | 3.85 |
EPS Estimate Current Year | 3.85 |
Biogen Inc.’s earning per share (EPS) estimates for the current quarter stand at 3.85 - a -0.77% fall from last quarter’s estimates.
Biogen Inc.’s earning per share (EPS) estimates for the current year stand at 3.85.
Earning Per Share (EPS) | 0 |
Biogen Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Biogen Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-10-29 | 3.85 | 0 | -100% |
2025-05-01 | 2.95 | 3.02 | 2.37% |
2025-07-31 | 3.88 | 5.47 | 40.98% |